en
Scientific article
Meta-analysis
Open access
English

Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection

Published inThe Journal of Infectious Diseases, vol. 221, no. 3, p. 356-366
Publication date2020
Abstract

The effect of neuraminidase inhibitor (NAI) treatment on length of stay (LoS) in patients hospitalized with influenza is unclear.

Keywords
  • IPD meta-analysis
  • Neuraminidase inhibitors
  • Antivirals
  • Length of stay
  • Pandemic influenza
  • Adolescent
  • Adrenal Cortex Hormones/therapeutic use
  • Adult
  • Aged
  • Anti-Bacterial Agents/therapeutic use
  • Antiviral Agents/therapeutic use
  • Child
  • Enzyme Inhibitors/pharmacology/therapeutic use
  • Female
  • Humans
  • Influenza A Virus, H1N1 Subtype
  • Influenza, Human/drug therapy/epidemiology
  • Length of Stay
  • Male
  • Middle Aged
  • Neuraminidase/antagonists & inhibitors
  • Pandemics
  • Treatment Outcome
  • Young Adult
Citation (ISO format)
VENKATESAN, Sudhir et al. Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection. In: The Journal of Infectious Diseases, 2020, vol. 221, n° 3, p. 356–366. doi: 10.1093/infdis/jiz152
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal0022-1899
140views
47downloads

Technical informations

Creation04/26/2021 10:57:00 AM
First validation04/26/2021 10:57:00 AM
Update time03/16/2023 12:35:55 AM
Status update03/16/2023 12:35:50 AM
Last indexation02/12/2024 1:26:31 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack